Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
AI-based prognosis and therapy response prediction from pathology images Iurii Tolkach Institute of Pathology, University Hospital Cologne PLCO Jan 9, 2024 PLCOI-1441
Pan-cancer digital pathology AI foundation model and its application in cancer prognostication Jan Witowski Ataraxis AI, Inc. PLCO Jan 9, 2024 PLCOI-1433
Risk prediction of prostate cancer mortality in a screening cohort. Patrick Lewicki University of Michigan PLCO Jan 9, 2024 PLCO-1439
Statistical Modeling on Lung Cancer Thang Nguyen University of South Florida PLCO Jan 4, 2024 PLCO-1434
A Bayesian proportional hazards mixture cure model for partly interval-censored data Chun Pan Hunter College PLCO Jan 4, 2024 PLCO-1437
Assessing the Role of Colorectal Cancer Screening in Reducing Racial Disparities in Prevention Behaviors and Health Outcomes Between Black and White Participants Christian Okitondo University of Georgia PLCO Jan 4, 2024 PLCO-1435
Neighborhood disadvantage and aggressive prostate cancer among African American and European American men Kathryn Barry University of Maryland, Baltimore PLCO Dec 26, 2023 PLCO-1428
MERGE: A consortium for male breast cancer genetics Thomas Ahearn NCI PLCO Dec 26, 2023 PLCO-1423
Chances of Prostate Cancer Classification Problem Joao Vitor De Alvarenga Ferreira Joao Vitor de Alvarenga Ferreira PLCO Dec 18, 2023 PLCO-1424
A new standardized incidence ratio metric for second primary cancer among cancer survivors by accounting for competing risks Summer Han Stanford University School of Medicine PLCO Dec 18, 2023 PLCO-1419
Investigating Trends in the Prevalence and Incidence of High Grade Prostate Cancer in Appalachia vs. National Data Justyn Blankenship Marshall University School of Medicine PLCO Dec 11, 2023 PLCO-1418
Validation of cancer cell morphological diversity-based prognostic biomarkers Ruijiang Li Stanford University PLCO Dec 11, 2023 PLCOI-1413
Validation of a radiolological report generation model for chest radiographs Hyungjin Kim Seoul National University Hospital PLCO Dec 4, 2023 PLCOI-1404
Mapping the progression of COPD to Lung Cancer Tej Pandya Francis Crick Institute PLCO Dec 4, 2023 PLCO-1401
PROPOSAL FOR A METHODOLOGY FOR THE EARLY CLASSIFICATION OF THE POPULATION AT RISK OF CANCER Carlos Andres Munoz Pineda Universidad Internacional de la Rioja PLCO Dec 4, 2023 PLCO-1403
A Mendelian Randomization study of alcohol intake and health effects in the PLCO study Yingxi Chen National Cancer Institute PLCO Nov 16, 2023 PLCO-1392
External validation of a risk stratification tool for ovarian cancer using PLCO data Celeste Leigh Pierce University of Wisconsin-Madison PLCO Nov 15, 2023 PLCO-1393
Survival analysis in oncology clinical trial and its use in actuarial science Patrícia Teplanová Faculty of Economic Informatics, University of Economics in Bratislava PLCO Nov 13, 2023 PLCO-1389
A prospective study on air pollution exposure and incidence of aerodigestive tract cancer Amanda Dilger Mass General Brigham PLCO Nov 13, 2023 PLCO-1381
Operationalizing recommendations for chronic disease and cancer prevention into a composite score Rebecca Seguin-Fowler Texas A&M AgriLife Research PLCO Nov 13, 2023 PLCO-1379